BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23170157)

  • 1. Short and long-term outcomes of diabetes mellitus in patients with autoimmune pancreatitis after steroid therapy.
    Miyamoto Y; Kamisawa T; Tabata T; Hara S; Kuruma S; Chiba K; Inaba Y; Kuwata G; Fujiwara T; Egashira H; Koizumi K; Sekiya R; Fujiwara J; Arakawa T; Momma K; Asano T
    Gut Liver; 2012 Oct; 6(4):501-4. PubMed ID: 23170157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin secretion improvement during steroid therapy for autoimmune pancreatitis according to the onset of diabetes mellitus.
    Noguchi K; Nakai Y; Mizuno S; Isayama H; Hirano K; Kanai S; Nakamura T; Uchino R; Takahara N; Kogure H; Tada M; Koike K
    J Gastroenterol; 2020 Feb; 55(2):198-204. PubMed ID: 31471733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan.
    Nishimori I; Tamakoshi A; Kawa S; Tanaka S; Takeuchi K; Kamisawa T; Saisho H; Hirano K; Okamura K; Yanagawa N; Otsuki M;
    Pancreas; 2006 Apr; 32(3):244-8. PubMed ID: 16628078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis.
    Ito T; Nakamura T; Fujimori N; Niina Y; Igarashi H; Oono T; Uchida M; Kawabe K; Takayanagi R; Nishimori I; Otsuki M; Shimosegawa T
    J Dig Dis; 2011 Jun; 12(3):210-6. PubMed ID: 21615876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus in patients with type 1 autoimmune pancreatitis at diagnosis and after corticosteroid therapy.
    Li MZ; Guo T; Feng YL; Zhang SY; Bai XY; Wu X; Xu K; Yang AM
    Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):393-398. PubMed ID: 37121837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy.
    Kamisawa T; Egawa N; Inokuma S; Tsuruta K; Okamoto A; Kamata N; Nakamura T; Matsukawa M
    Pancreas; 2003 Oct; 27(3):235-8. PubMed ID: 14508128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study.
    Kamisawa T; Yoshiike M; Egawa N; Nakajima H; Tsuruta K; Okamoto A
    Pancreatology; 2005; 5(2-3):234-8; discussion 238-40. PubMed ID: 15855821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term and long-term outcomes of autoimmune pancreatitis.
    Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Igarashi Y
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):146-52. PubMed ID: 21287714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
    Miyazawa M; Takatori H; Shimakami T; Kawaguchi K; Kitamura K; Arai K; Matsuda K; Sanada T; Urabe T; Inamura K; Kagaya T; Mizuno H; Fuchizaki U; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
    PLoS One; 2017; 12(11):e0188549. PubMed ID: 29166415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis.
    Masuda A; Shiomi H; Matsuda T; Takenaka M; Arisaka Y; Azuma T; Kutsumi H
    Pancreatology; 2014; 14(5):361-5. PubMed ID: 25278305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant Improvement of Alpha Cell Function after Steroid Therapy in a Patient with Autoimmune Pancreatitis: Case Report.
    Takeshima K; Ariyasu H; Iwakura H; Kawai S; Uraki S; Inaba H; Furuta M; Warigaya K; Murata SI; Akamizu T
    Diabetes Ther; 2018 Jun; 9(3):1385-1395. PubMed ID: 29725970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan.
    Takikawa T; Kikuta K; Sano T; Ikeura T; Fujimori N; Umemura T; Naitoh I; Nakase H; Isayama H; Kanno A; Kamata K; Kodama Y; Inoue D; Ido A; Ueki T; Seno H; Yasuda H; Iwasaki E; Nishino T; Kubota K; Arizumi T; Tanaka A; Uchida K; Matsumoto R; Hamada S; Nakamura S; Okazaki K; Takeyama Y; Masamune A;
    Pancreatology; 2024 May; 24(3):335-342. PubMed ID: 38336506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.
    Matsubayashi H; Ishiwatari H; Imai K; Kishida Y; Ito S; Hotta K; Yabuuchi Y; Yoshida M; Kakushima N; Takizawa K; Kawata N; Ono H
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of steroid therapy on pancreatic exocrine function in autoimmune pancreatitis.
    de Pretis N; Martinelli L; Palmeri E; Caldart F; Crucillà S; Zorzi A; Brillo A; Crinò SF; Conti Bellocchi MC; Bernardoni L; De Marchi G; Amodio A; Campagnola P; Ciccocioppo R; Gabbrielli A; Marcon A; Frulloni L
    Pancreatology; 2024 Jun; 24(4):538-544. PubMed ID: 38693038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exocrine and Endocrine Insufficiency in Autoimmune Pancreatitis: A Matter of Treatment or Time?
    Nikolic S; Maisonneuve P; Dahlman I; Löhr JM; Vujasinovic M
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study.
    Moon SH; Kim MH; Park DH; Hwang CY; Park SJ; Lee SS; Seo DW; Lee SK
    Gut; 2008 Dec; 57(12):1704-12. PubMed ID: 18583399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of autoimmune pancreatitis.
    Kamisawa T; Okamoto A
    J Gastroenterol; 2007 May; 42 Suppl 18():59-62. PubMed ID: 17520225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exocrine and endocrine pancreatic function in 21 patients suffering from autoimmune pancreatitis before and after steroid treatment.
    Frulloni L; Scattolini C; Katsotourchi AM; Amodio A; Gabbrielli A; Zamboni G; Benini L; Vantini I
    Pancreatology; 2010; 10(2-3):129-33. PubMed ID: 20460944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids.
    Ohno Y; Kumagi T; Yokota T; Azemoto N; Tanaka Y; Tange K; Inada N; Miyata H; Imamura Y; Koizumi M; Kuroda T; Hiasa Y;
    Orphanet J Rare Dis; 2016 Jul; 11(1):103. PubMed ID: 27465035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural course of autoimmune pancreatitis.
    Kamisawa T; Anjiki H; Takuma K; Egawa N; Kubota N
    Hepatogastroenterology; 2009; 56(91-92):866-70. PubMed ID: 19621719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.